Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene

Biochemical and Biophysical Research Communications

Volumn 249, Issue 2, 1998, Pages 517-521

  Bakker, Onno ^a   Hudig, Francisca ^a   Meijssen, Sharon ^a   Wiersinga, Wilmar M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DEETHYLAMIODARONE; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA TRANSFECTION; GENE DELETION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; TRANSCRIPTION REGULATION;

EID: 0032547291     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.9174     Document Type: Article

References (32)

1. Bhattacharya S., Balasubramaniam S., Simons L. A. Biochem. J. 234:1986;493-496.
2. Soutar A. K., Knight B. L. Br. Med Bull. 46:1990;891-916.
3. Chait A., Bierman E. L., Albers J. Clin. Endocrin. Metab. 48:1979;887-889.
4. Steals B., van Tol A., Chan L., Will H., Verhoeven G., Auwerx J. Endocrinology. 127:1990;1144-1152.
5. Ness G. C., Pendelton L. C., Li Y. C., Chang J. Y. Biochem. Biophys. Res Com. 172:1990;1150-1156.
6. Abrams J. J., Grundy S. M. J. Lipid Res. 22:1981;323-338.
7. Salter A. M., Hayashi R., Al-Seeni M., Brown N. F., Bruce J., Sorensen O., Atkinson E. A., Middelton B., Bleackley C., Brindley D. N. Biochem. J. 276:1991;825-832.
8. Wiersinga W. M., Trip M. D., van Beeren H. C., Plomp T. A., Oosting H. Ann. Intern. Med. 114:1991;128-132.
9. Wiersinga W. M., Broenink M. Horm. Metab. Res. 23:1991;94-95.
10. Hudig F., Bakker O., Wiersinga W. M. FEBS letters. 341:1994;86-90.
11. Hudig F., Bakker O., Wiersinga W. M. Metabolism. 1998.
12. de Jong M., Docter R., van der Hoek H. J., Krenning E. P., van der Heide D., Quero C., Plaisier P., Vos R. A., Hennemann G. Am. J. Physiol. 266:1994;E44-E49.
13. Sogol P. B., Hershman J. M., Reed A. W., Dillman W. H. Endocrinology. 113:1983;1464-1469.
14. Bakker O., van Beeren H. C., Wiersinga W. M. Endocrinology. 134:1994;1665-1670.
15. van Beeren H. C., Bakker O., Wiersinga W. M. Mol. Cel. Endocrinol. 112:1995;15-19.
16. Hudig F., Bakker O., Wiersinga W. M. J. Endocrinol. 152:1997;413-421.
17. Sudhof T. C., Russell D. W., Brown M. S., Goldstein J. L. Cell. 48:1987;1061-1069.
18. Südhof T. C., Goldstein J. L., Brown M. S., Russell D. W. Science. 228:1985;815-822.
19. Thompson C. C., Evans R. M. Proc. Natl. Acad. Sci. USA. 86:1989;3494-3498.
20. Gorman, C. 1985, in, DNA cloning vol II; a Practical approach, 143, 191, IRL Press, Oxford, Washington, DC.
21. Oppenheimer, J. H. Schwartz, H. L. Strait, K. A. 1996, in, Werner and Ingbar's the Thyroid, Braverman, L. E.Utiger, R. D. 162, 184.
22. Damm K., Thompson C. C., Evans R. M. Nature. 339:1989;593-597.
23. Sap J., Munoz A., Scgmitt J., Stunnenberg H., Vennström B. Nature. 340:1989;242-244.
24. Graupner G., Wills K. N., Tzukerman M., Zhang X., Pfahl M. Nature. 340:1989;653-656.
25. Yen P. M., Brubacker J. H., Apriletti J. W., Baxter J. D., Chin W. W. Endocrinology. 134:1994;1075-1081.
26. Plomp T. A., Robles D. M., Maes R. A. Top. Foren. Anal. Toxicol. 20:1984;105-111.
27. Berger, Y. Harris, L. 1986, in, Amiodarone, Harris, L.Roncucci, R. 46, 98, Medicine et Sciences Internationales, Paris.
28. Wiersinga, W. M. 1997, in, Handbook of Experimental Pharmacology, Vol. 128. Pharmacotherapeutics of the thyroid gland, Weetman, A. P.Grossman, A. 225, 287, Springer-Verlag, Berlin, Heidelberg.
29. van Beeren H. C., Bakker O., Wiersinga W. M. J. Endocrinol. Invest. 20:1997;69.
30. Henttu P. M., Kalkhoven E., Parker M. G. Mol. Cell. Biol. 17:1997;1832-1839.
31. Yoh S. M., Chatterjee V. K. K., Privalsky M. L. Mol. Endocrinol. 11:1997;470-480.
32. Horlein A. J., Heinzel T. H., Rosenfeld M. G. Curr. Opin. Endocrinol. Diab. 3:1996;412-416.